BYETTA LAWSUIT: WHAT YOU NEED TO KNOW ABOUT THE SERIOUS BYETTA SIDE EFFECTS

​If you or a loved one took Byetta and were diagnosed with pancreatic cancer, Contact Byetta lawsuit lawyer Timothy L. Miles today

​​​Byetta (exenatide) was the first of a new class drugs used to treat type 2 diabetes drugs known as glucagon-like peptide 1 (GLP-1) receptor agonists which generated a lot of early excitement with added benefits including a low risk of hypoglycemia and successful weight loss. However, early optimism was halted by reports that Byetta and similar drugs were a possible risk factor for pancreatitis and pancreatic cancer.​

There have been hundreds of pancreatic cancer lawsuits filed against the manufacturers of Byetta, Victoza, Janument, and Januvia.  These lawsuits were all transferred the Southern District of California by the Judicial Panel on Multidistrict Litigation for coordinated and pretrial discovery and proceedings.  A ruling by the trial judge in 2015 appeared to end the case until a recent court of appeals decision in favor of the Byetta plaintiffs holding their claims may proceed in federal court.

If you or a loved one took Byetta and were diagnosed with pancreatic cancer, contact Byetta lawsuit lawyer Timothy L. Miles today to see if you are eligible for Byetta lawsuit and possible entitled to substantial damages. (855) Tim-M-Law (855-846-6529).

what is byetta?

Byetta (exenatide) is a medicine used to treat type 2 diabetes. It is glucagon-like peptide-1 (GLP-1) receptor agonist.  A receptor agonist drug means that it binds to a certain receptor and causes the same action as the substance that normally binds to that receptor.  Byetta, by binding to and activating the GLP-1 receptor, tells your body to release more insulin, stops the body from releasing more sugar, and slows down digestion.

Byetta is a solution for injection available in pre‑filled pens of 5mcg or 10 mcg. The shots are given by the patient twice a day by injection under the skin in the abdomen, thigh or upper arm. ​The starting dose of Byetta is 5 mcg, twice a day before a meal.  After four weeks, the dose can be increased to 10 mcg depending ​on how well your blood sugar levels respond to Byetta injections.

WHAT IS THE PROBLEM WITH BYETTA?

Incretin mimetic drugs such as Byetta regulate the production of incretin, a type of hormone that stimulates the release of insulin in the body. Byetta does this by injecting patients with a substance that mimics a particular incretin called Glucagon-Like Peptide-1 (GLP-1).  Byetta lawsuits allege this process overstimulates the pancreas causing cells in the pancreas to multiply resulting in pancreatic cancer.

BYETTA SIDE EFFECTS

​Byetta side effects include, among others:

• Pancreatic inflammation
• Pancreatitis
• Chronic pancreatitis
• Acute pancreatitis
• Necrotizing pancreatitis
• Hemorrhagic pancreatitis
• Pancreatic cancer
• Thyroid cancer
• Kidney damage
• Low blood-sugar (hypoglycemia)
• Nausea
• Vomiting
• Diarrhea
• Decreased appetite
• And more

Certain people can have an allergic reaction after taking Byetta. The symptoms of a mild allergic reaction can include:

• skin rash
• itchiness
• flushing (warmth and redness in your skin)

A more severe allergic reaction to Byetta is rare but possible.  The symptoms of a severe allergic reaction can include:

• swelling under your skin, typically in your eyelids, lips, hands, or feet
• swelling of your tongue, mouth, or throat
• trouble breathing
• chest tightness

You should call your doctor right away if you have a severe allergic reaction to Byetta and if your symptoms feel life threatening you should call 911.

IS THERE A LINK BETWEEN BYETTA AND PANCREATIC CANCER?

A number of scientific studies support plaintiff claims that Byetta causes pancreatic cancer.

• In 2010, researchers wrote in the journal Diabetes Care that “there is a plausible risk that long-term recipients of GLP-1-based therapy may develop asymptomatic pancreatitis… and worse, a minority of individuals treated by this class of drugs may develop pancreatic cancer.”
• Research published in 2011 in the journal Gastroenterology found a reported event rate for pancreatic cancer that was 2.9 times greater in patients treated with Byetta compared to those treated with other diabetes medications.
• Adverse event data from the Drug Commission of the German Medical Association found an unusually high incidence of pancreatic cancer associated with Byetta. The data showed an average of 12.2 months between the start of treatment with Byetta and a diagnosis of pancreatic cancer.
• A case-controlled epidemiological study on the effect of GLP-1 drugs on the pancreas published in JAMA in 2013 concluded that an association between GLP-1s and pancreatitis “may be causal.” This is significant because antecedent pancreatitis is the most common risk factor for subsequent pancreatic cancer.

WHAT ARE THE SYMPTOMS OF PANCREATITIS?

​​Pancreatitis, an inflammation of the pancreas, can cause the following symptoms, among others:

• Severe upper abdominal pain which may radiate through the back
• Nausea
• Vomiting
• High blood pressure (hypertension)
• Low blood pressure (hypotension)
• Elevated heart or respiratory rates

It is not known for certain if Byetta or other similar incretin mimetic diabetes drugs can cause pancreatic cancer. However, Incretin mimetics treat type 2 diabetes by mimicking the action of GLP-1, a hormone that stimulates the pancreas to produce more insulin.  In certain people, this could possibly cause chronic inflammation of the pancreas, also known as pancreatitis, which is a known risk factor for pancreatic cancer.

CALL A BYETTA LAWSUIT LAWYER IF YOU TOOK BYETTA AND WERE DIAGNOSED WITH PANCREATIC CANCER

​​If you or a loved one took Byetta and were diagnosed with pancreatic cancer, you may be eligible to file a Byetta lawsuit. Contact Byetta lawsuit lawyer Timothy L. Miles today and see if you meet the requirements for a Byetta lawsuit and could be eligible for substantial compensation. (855) Tim-M-Law (855-846-6529)​.

TIMOTHY L. MILES, ESQ.

Timothy L. Miles is a nationally recognized shareholder and consumer rights attorney raised in Nashville, Tennessee. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2023 Top Ranked Lawyer, 2023 Top Rated Litigator. and a 2023 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, and more.  ​